Stroke resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:
===Common Causes===
===Common Causes===
==Management==
==Management==
{{familytree/start}}
{{familytree/start}}
{{familytree | | | | | | | | | | | | | | | | | | | | A01 |-|-|-|-|-|-| A02 |A01=<u>Evaluation</u><br>'''Goal: Evaluation done within 60 mins of patient's arrival'''<ref name="Jauch-2013">{{Cite journal  | last1 = Jauch | first1 = EC. | last2 = Saver | first2 = JL. | last3 = Adams | first3 = HP. | last4 = Bruno | first4 = A. | last5 = Connors | first5 = JJ. | last6 = Demaerschalk | first6 = BM. | last7 = Khatri | first7 = P. | last8 = McMullan | first8 = PW. |last9 = Qureshi | first9 = AI. | title = Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. | journal = Stroke | volume = 44 | issue = 3 | pages = 870-947 | month = Mar | year = 2013 |doi = 10.1161/STR.0b013e318284056a | PMID = 23370205 }}</ref><br><br>Check vitals<br>ABCs<br>Rapid Hx - time of onset, time of arrival at the ED, medications (especially anticoagulants)<br>Rapid physical exam - neuro exam, '''NIHSS'''<br>Activate stroke team<br>'''Stat fingerstick'''<br>Labs<br>EKG, troponin, CXR<br>NPO<br>Obtain stroke protocol|A02=<u>Rule out DD</u><br>Seizure, syncope, migraine, hypoglycemia}}
{{familytree | | | | | | | | | | | | | | | | | | | | A01 |-|-|-|-|-|-| A02 |A01=<u>Evaluation</u><br>'''Goal: Evaluation done within 60 mins of patient's arrival'''<ref name="Jauch-2013">{{Cite journal  | last1 = Jauch | first1 = EC. | last2 = Saver | first2 = JL. | last3 = Adams | first3 = HP. | last4 = Bruno | first4 = A. | last5 = Connors | first5 = JJ. | last6 = Demaerschalk | first6 = BM. | last7 = Khatri | first7 = P. | last8 = McMullan | first8 = PW. |last9 = Qureshi | first9 = AI. | title = Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. | journal = Stroke | volume = 44 | issue = 3 | pages = 870-947 | month = Mar | year = 2013 |doi = 10.1161/STR.0b013e318284056a | PMID = 23370205 }}</ref><br><br>Check vitals<br>ABCs<br>Rapid Hx - time of onset, time of arrival at the ED, medications (especially anticoagulants)<br>Rapid physical exam - neuro exam, '''NIHSS'''<br>Activate stroke team<br>'''Stat fingerstick'''<br>Labs<br>EKG, troponin, CXR<br>NPO<br>Obtain stroke protocol|A02=<u>Rule out DD</u><br>Seizure, syncope, migraine, hypoglycemia}}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | |  }}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| }}
{{familytree | | | | | | | | | | | | | | | | | | | | B01 |-|-|-| B02 |-|-| B03 | | | | | | | | | | | | | | | | | |B01=Non-contrast enhanced CT (or MRI) to r/o hemorrhage|B02='''Bleed positive'''|B03='''Hemorrhagic stroke'''}}
{{familytree | | | | | | | | | | | | | | | | | | | | B01 |-|-|-| B02 |-|-| B03 |B01=Non-contrast enhanced CT (or MRI) to r/o hemorrhage|B02='''Bleed positive'''|B03='''Hemorrhagic stroke'''}}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | |!| | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | |!|}}
{{familytree | | | | | | | | | | | | | | | | | | | | C01 | | | | | | | | | C02 | | | | | | | | | | | | | | | | | |C01='''Bleed negative'''|C02=Hemorrhagic stroke algorithm}}
{{familytree | | | | | | | | | | | | | | | | | | | | C01 | | | | | | | | | C02 | | | | | | | | | | | | | | | | | |C01='''Bleed negative'''|C02=Hemorrhagic stroke algorithm}}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | }}
Line 23: Line 21:
{{familytree | | | | | | | | | | | | | |!| | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | |!| | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | G01 | | | | | G02 | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | |G01=Eligibility criteria for IV rTPA|G02=Consider rTPA after '''excluding''' patients >80 years old, those taking anticoagulants regardless of INR, baseline NIHSS >25, those with imaging evidence of ischemic injury involving >1/3 of the MCA territory, or those with a history of both stroke and diabetes mellitus}}
{{familytree | | | | | | | | | | | | | G01 | | | | | G02 | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | |G01=Eligibility criteria for IV rTPA|G02=Consider rTPA after '''excluding''' patients >80 years old, those taking anticoagulants regardless of INR, baseline NIHSS >25, those with imaging evidence of ischemic injury involving >1/3 of the MCA territory, or those with a history of both stroke and diabetes mellitus}}
{{familytree | | | | | | | | | | | | | |!| | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | |  }}
{{familytree | | | | | | | | | | | | | |!| | | | | | |!| | | | | | |!| |}}
{{familytree | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|.| | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|.| | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | H01 | | | | | | | | | | H02 | |!| | | | | | H03 | | | | | | | | | | | | | | | | | | | | | | |H01=Eligible|H02=Not eligible|H03=Blood pressure control algorithm<br><br>Treat fever with IV antipyretics}}
{{familytree | | | | | H01 | | | | | | | | | | H02 | |!| | | | | | H03 | | | | | | | | | | | | | | | | | | | | | | |H01=Eligible|H02=Not eligible|H03=Blood pressure control algorithm<br><br>Treat fever with IV antipyretics}}

Revision as of 21:49, 3 December 2013

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Definition

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Management

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluation
Goal: Evaluation done within 60 mins of patient's arrival[1]

Check vitals
ABCs
Rapid Hx - time of onset, time of arrival at the ED, medications (especially anticoagulants)
Rapid physical exam - neuro exam, NIHSS
Activate stroke team
Stat fingerstick
Labs
EKG, troponin, CXR
NPO
Obtain stroke protocol
 
 
 
 
 
 
Rule out DD
Seizure, syncope, migraine, hypoglycemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-contrast enhanced CT (or MRI) to r/o hemorrhage
 
 
 
Bleed positive
 
 
Hemorrhagic stroke
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bleed negative
 
 
 
 
 
 
 
 
Hemorrhagic stroke algorithm
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acute ischemic stroke
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{{{ }}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time of onset
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<3 hours
 
 
 
 
3 -4.5 hours
 
 
 
 
>4.5 hours
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eligibility criteria for IV rTPA
 
 
 
 
Consider rTPA after excluding patients >80 years old, those taking anticoagulants regardless of INR, baseline NIHSS >25, those with imaging evidence of ischemic injury involving >1/3 of the MCA territory, or those with a history of both stroke and diabetes mellitus
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eligible
 
 
 
 
 
 
 
 
 
Not eligible
 
 
 
 
 
 
 
 
Blood pressure control algorithm

Treat fever with IV antipyretics
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BP≤180/110
 
 
 
 
 
BP≥180/110
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{{{ }}}
IV rTPA 0.9 mg/kg (maximum of 90 mg) with 10% given as intravenous bolus over 1 minute and the rest as IV infusion over 1 hour
 
 
 
 
 
Commence IV antihypertensives
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Admit ICU for BP monitoring + bleeding complications
Vitals
Neurocheck hourly
Aspiration precautions
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After 24 hours post rTPA or no rTPA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Follow-up head CT/MRI before commencing antiplatelets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASA 325 mg (if no contraindication)
Statins
DVT prophylaxis
 
 
 
PTOT evaluation
Speech and swallow evaluation
 
 
 
 
Investigate the cause
MRA/CTA/carotid duplex
Venous doppler USS
Echocardiography
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Dos

Don'ts

References

  1. Jauch, EC.; Saver, JL.; Adams, HP.; Bruno, A.; Connors, JJ.; Demaerschalk, BM.; Khatri, P.; McMullan, PW.; Qureshi, AI. (2013). "Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association". Stroke. 44 (3): 870–947. doi:10.1161/STR.0b013e318284056a. PMID 23370205. Unknown parameter |month= ignored (help)

Template:WH Template:WS